Show simple item record

dc.contributor.advisorAnsari, Fereshteh
dc.contributor.authorSoleimani, Niloofar
dc.date.accessioned2023-05-23T04:48:26Z
dc.date.available2023-05-23T04:48:26Z
dc.date.issued2022en_US
dc.identifier.urihttps://dspace.tbzmed.ac.ir:443/xmlui/handle/123456789/68743
dc.description.abstractDuchenne Muscular Dystrophy (DMD) is the most common form of muscular dystrophy in childhood, caused by deletion in the DMD gene. It often causes progressive weakness starting in childhood and become wheelchairs bounde. Premature deaths occur in the early twenties due to cardiovascular problems. Prednisolone treatment in these patients is associated with complications such as weight gain, cushingoid appearance, hirsutism, glucose intolerance, and delayed puberty cataracts. In this study, the effect of oral supplements in people with Duchenne dystrophic disease was evaluated, so that the results of the systematic review of these studies can be used for other patients. Materials and Methods: After extracting from the target databases, the keywords were evaluated by two evaluators using the CONSORT evaluation checklist for various types of bias risks. Studies were evaluated using the article quality assessment checklist (CONSORT) and based on the agreement of two independent evaluators of article quality in accordance with existing standards in terms of types of bias risks including (selection, performance, identification, attrition, reports). After careful study and extraction of required information, the extracted results were first summarized by a pre-designed Extraction table in EXCEL software environment and the data required for meta-analysis entered into CMA software were analyzed. Data were analyzed by CMA (Comprehensive Meta-Analysis) software. Results: After the selection process was described using inclusion and exclusion criteria, 9 studies were eligible to be included in our systematic review. These 9 studies included 6 randomized double-blind randomized clinical trial studies. The other three studies were open-label, single-center, non-randomized pilot studies in the cohort study category. Supplements studied in this study: Omega 3 (2 articles), L-Citrulline (1 article), Calcium and vitamin D (2 articles), Creatine monohydrate (2 articles), Selenium and Vitamin E (1 article), glutamine and amino acid (A total of 252 boys were examined in these articles. Due to the dispersion between dietary supplements and response criteria, there was a statistically significant relationship between the total data, both in terms of type of oral supplement and type of response to treatment. There was nothing between them.en_US
dc.language.isofaen_US
dc.publisherTabriz University of Medical Sciences, Faculty of Medicineen_US
dc.relation.isversionofhttps://dspace.tbzmed.ac.ir:443/xmlui/handle/123456789/68742en_US
dc.subjectMuscular dystrophyen_US
dc.subjectoral supplementsen_US
dc.subjectmuscle strengthen_US
dc.subjectcorticosteroidsen_US
dc.titleSystematic review of therapeutic effectiveness of oral supplements on patients with Duchenne muscular dystrophiesen_US
dc.typeThesisen_US
dc.contributor.supervisorSalek Zamani, Yagoob
dc.contributor.supervisorToopchi Zadeh, Vahideh
dc.identifier.docno6010989en_US
dc.identifier.callno10989en_US
dc.description.disciplineEmergency Medicineen_US
dc.description.degreespecialty Degreeen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record